JP Morgan Maintains Overweight on Imax, Raises Price Target to $58
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
JP Morgan analyst David Karnovsky maintains Imax (NYSE:IMAX) with a Overweight and raises the price target from $50 to $58.
JP Morgan analyst David Karnovsky maintains Imax (NYSE:IMAX) with a Overweight and raises the price target from $50 to $58.
